OA 82-275S3) Although immunocytochemical results are rarely quantifiable today, it is well-recognized that the ultimate goal in many routine and research applications is quantitative measurement of tissue antigens. This trend is evident in several recent publications, even in the program of the present meeting.
Efficiency
Efficiency is a useful practical concept expressing the signalto-noise ratio in a preparation stained with any immunocytochemical technique. It is readily quantifiable as a density measurement (after subtraction of background) plotted against the dilution of the primary antiserum. The concept of efficiency in immunocytochemistry was introduced (Petrusz et al., 1975) in order to distinguish changes in staining intensitỳ Presented as part of the program at the 1982 Joint Meeting of the American and Japanese Histochemical Societies, held in Vancouver, British Columbia, Canada, July 20-24, 1982. due to antiserum dilution or other technical variations (signalto-noise ratio) from changes due to variations in the amount of tissue antigen in an otherwise standardized system (sensitivity). The "titration curve" obtained while assessing efficiency is an extremely useful first step in any immunocytochemical study as it helps to compare techniques, to characterize the primary antiserum for future use, and to determine method specificity (see below). It may also help to eliminate dilutiondependent false negative results (Bigbee et al., 1977) . 1 consider such a preliminary "titration" study to be one of the essential requirements for reliable immunocytochemical localization.
Accuracy and Precision
These terms are often used interchangeably and, therefore, incorrectly. Since every observation (0) is the sum of the "true value" (T) and the error component (E), 0 = T + E, the error can be thought of as the difference between the observed value and the true value:
The error, defined as above, is a measure of the accuracy of the observation. Accuracy, then, can be defined as the closeness of the observation to the true value. It is evident that the error can not be stated if the true value is not known, and it would seem that the true value can not be obtained unless the error is known. Any systematic error that would consistently appear in repeated observations will remain undetectable in a given system. Therefore, the accuracy of a result obtained with one method of observation can only be established by obtaining independent estimates of the true value with other methods of analysis. In contrast, precision refers to the variability of repeated observations (replications) made in the same system. Precision is independent of the magnitude of the error itself and can be estimated by generally known statistical parameters (e.g., variance, standard deviation, or various compos-PETRUSZ ite indices). It follows that the accuracy of an immunocytochemical result (i.e., whether it reflects the true amount of the tissue antigen present) can only be assessed by applying other techniques to verify the immunocytochemical observation, while the precision can be determined simply by using a suitable number of replicates. Thus, high accuracy can not be obtained without high precision, but high precision alone does not guarantee accuracy. A common fallacy is to believe that close agreement between repeated observations indicates accuracy.
To ensure the best achievable precision and accuracy, it is important to keep the controllable errors and random variation in the technique as low as possible by rigorous standardization of all steps of the method used. This can be considered another essential requirement for reliable immunocytochemistry.
Sensitivity
The sensitivity of an immunocytochemical method can be defined as the lowest detectable amount or concentration of the tissue antigen. This is represented by the lowest staining intensity that can be distinguished from background. However, the confidence with which such a distinction can be made depends on the variability (precision) of the method. Thus, high efficiency (high signal-to-noise ratio) and high precision (low variability) are essential for high sensitivity. The actual detection limit of today's immunocytochemical techniques is difficult to estimate. Although several model systems have been proposed (cf. Larsson (1981) ), it is not clear that these are able to determine the actual limits of detection, and their use remains largely experimental or comparative. Calculated detection limits are as low as 0.1 fg (10 -"g) of protein antigen (cf. Petrusz et al. (1980) ). It is clear that modern immunocytochemical techniques are sensitive enough to provide use-fuI answers to a variety of biological questions of current interest (e.g., detection of cell surface antigens, receptor-bound ligands, single cells or subcellular compartments containing a given antigen, etc.). One common source of error in the interpretation of immunocytochemical results is the failure to realize that even the most sensitive technique has its limits below which it is not capable of producing a detectable signal. Reports that a certain antigen is "absent" from a given site or tissue should be evaluated in this light. Indeed, there are many examples in the literature for the demonstration of the presence of tissue antigens by improved technology at sites where they were previously reported to be "absent."
Specificity
Of all the criteria of validity for immunocytochemical staining, specificity is the most important and the most difficult to define. Specificity can be regarded as the ability of antibodies to detect one antigenic determinant to the exclusion of all others. It is convenient to discuss specificity in terms of two sets of criteria: method specificity and antibody specificity. Method specificity indicates the lack of staining due to interactions of tissue components with staining reagents other than the an-tibodies directed against the tissue antigen to be localized. Simply stated, method specificity is equivalent to the lack of any kind of artifact. Testing for the presence and sources of method nonspecificity is relatively easy. A series of dilutions or omission of each reagent, tested one at a time, should pinpoint the source of any method nonspecificity. Methods should be standardized in advance so that reagents other than the primary antiserum do not produce any detectable staining. Subsequently, routine tests need to include only a dilution series of the primary antiserum. A potentially most treacherous form of method nonspecificity arises from the binding of immunoglobulins to the tissue by mechanisms other than the intended "specific" antigen-antibody reaction (e.g., Buffa et al., (1979) and Grube (1980) ). When this happens with immunoglobulins present in the primary antiserum, a simple dilution series may not identify the staining as nonspecific. This is one situation in which substitution of the primary antiserum with other sera from the same species (including preimmune serum) will be informative: a dilution-dependent staining of identical distribution with all sera will clearly indicate this sort of method nonspecificity. Fortunately (cf. Grube (1980) ), use of higher dilutions of the primary antiserum will tend to favor the specific staining and can in fact eliminate the problem. A more common but less dangerous type of method nonspecificity depends on components of the second-layer anti-immunoglobulin serum reacting directly with the tissue, resulting in false positive staining. However, since these reactions are usually of lower affinity than the specific antigenantibody reaction, they can be effectively prevented by incubations of the sections with diluted normal serum of the species from which the second-layer antiserum is derived. Our routine technique includes such "blocking" steps with 2% normal sheep serum prior to the applications of both the primary and the secondary antisera.
Problems related to antibody specificity are more difficult to solve. There are many pitfalls that have been pointed out repeatedly in the literature (Petrusz et al., 1976; Swaab et al., 1977; Sternberger, 1979; Petrusz et al., 1980; Larsson, 1981; Van Leeuwen, 1982; Halmi and Krieger, 1982) . Antibody specificity, as it is related to immunocytochemical staining, can be understood on the basis of the following fundamental principles: Antibodies recognize relatively small regions or sites on the surface of larger antigenic molecules and thus are inherently incapable of identifying the molecules themselves. In practice, the recognition site can be characterized by allowing the antibodies to react with known (preferably highly purified or synthetic) antigens. Antigens that contain the critical site will block the immunostaining (the absorption test). The detected site in the tissue may be contained not only within the antigen one intends to localize but also within precursors or fragments of the same molecule, within related molecules, and even within unrelated (cross-reacting) molecules. It must be clearly understood that immunocytochemical specificity tests reflect only regional or site specificity, and not molecular specificity. If the recognized site (or a site very similar to it) occurs in several different molecules, it is not reasonable to expect that immunocytochemistry with antibodies directed to that site will be able to distinquish between such molecules. This is well-demonstrated in the example described by Swaab et al. (1977) . In such a case, one either has to use antibodies directed against dissimilar portions of the molecules in question, or has to resort to techniques other than immunocytochemistry. These considerations apply to both conventional and monoclonal antibodies.
It has been pointed out repeatedly that radioimmunoassay characterization of the antisera is not sufficient proof of their immunocytochemical specificity (Petrusz et al., 1976 (Petrusz et al., , 1980 Van Leeuwen, 1982) . It is also important to keep in mind that the value of the absorption test critically depends on the purity of the antigen preparation used.
Essential Requirements of Validity
Besides a reliable technique, nothing is more important in immunocytochemistry than the careful design of experiments to incorporate appropriate and informative controls and the correct interpretation of the results. In summary, the minimum requirements for valid immunocytochemical staining should include all of the following:
1. Careful preliminary standardization of all steps of the method. 2. Use of increasing dilutions (titration) of the primary antiserum up to a dilution where all immunostaining disappears; this may be supplemented with the replacement of the primary antiserum by other antisera and/or preimmune serum. 3. Tests of antiserum specificity to demonstrate inhibition of the staining with homologous antigen and, if feasible, lack of such inhibition with heterologous (but relevant) antigens. 4. Use of all other relevant (biochemical, physiological, etc.) information to support the validity of the localization (e.g., reliable positive and negative controls, demonstration of physiological changes, etc.).
One must recognize that in some cases, especially in pathologic diagnosis, even these minimal criteria can not be met in practice due to unavailability of materials (tissue, antisera, purified antigen). In such cases, more reliance must be placed on indirect evidence, such as in point 4 above, and it is even more important to interpret the results with great caution.
